NCT03327623Completed
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
A Prevalence and Incidence Study Investigating the Burden of Atrial and Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy and Sleep Apnea.
Source: ClinicalTrials.gov · Last updated 26 Mar 2025
Brief summary (registry, in English)
The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if its presence is associated with changes in the functioning of the body. The investigators want to determine if sleep apnea is associated with electrical disorders of the heart in patients with hypertrophic cardiomyopathy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 290 (actual)
- First submitted
- 25 Oct 2017
- Start date
- 13 Nov 2017
- Primary completion date
- 21 Jun 2024
- Lead sponsor
- Mayo Clinic
- Diseases
- Hypertrophic cardiomyopathy
- NCT number
- NCT03327623
What you commit to
- Study type: Observational
- Participants enrolled: 290
- From 13 Nov 2017 to the primary completion date, 21 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Decompensated Heart failure at time of enrollment (prior history of HF is not an exclusion criteria)
Other illness
- Severe (known) Chronic obstructive pulmonary disease (COPD) (FEV1 between 30 and 50 percent of normal)
Other
- Vulnerable study populations except for minorities (minorities may be targeted to achieve 25% minority recruitment required by the NIH)
- Pregnant women
- Children
Who the study is looking for
- Adults with a diagnosis of HCM
- Able to consent
- Non-pregnant
- Healthy Controls free of hypertrophic cardiomyopathy and without a definitive family history of hypertrophic cardiomyopathy.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.